Nathalie Vergnolle Selected Research

Colonic Neoplasms (Colon Cancer)

12/2020	Colon-specific immune microenvironment regulates cancer progression versus rejection.
1/2016	PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathalie Vergnolle Research Topics

Disease

64	Inflammation (Inflammations) 01/2023 - 04/2002
22	Pain (Aches) 01/2021 - 10/2003
17	Colitis 09/2021 - 09/2003
16	Hyperalgesia 12/2018 - 03/2002
12	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2021 - 11/2002
10	Neoplasms (Cancer) 01/2024 - 06/2005
10	Hypersensitivity (Allergy) 01/2019 - 03/2007
9	Visceral Pain 01/2021 - 04/2002
7	Infections 01/2016 - 04/2006
6	Edema (Dropsy) 05/2013 - 09/2007
5	Crohn Disease (Crohn's Disease) 11/2021 - 11/2002
5	Ischemia 11/2017 - 07/2006
4	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2016
4	Abdominal Pain (Pain, Abdominal) 12/2018 - 01/2012
4	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/2018 - 03/2007
3	Ulcerative Colitis 01/2022 - 11/2002
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 03/2010
3	Neuroinflammatory Diseases 10/2007 - 06/2005
3	Neurogenic Inflammation 09/2007 - 09/2003
2	Intestinal Diseases (Diseases, Intestinal) 01/2023 - 09/2003
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2021 - 01/2020
2	Cystitis 01/2021 - 05/2013
2	Colonic Neoplasms (Colon Cancer) 12/2020 - 01/2016
2	Celiac Disease (Celiac Sprue) 01/2019 - 05/2014
2	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2007
2	Hemorrhage 01/2018 - 05/2013
2	Experimental Arthritis 01/2017 - 11/2009
2	Arthritis (Polyarthritis) 01/2017 - 04/2005
2	Communicable Diseases (Infectious Diseases) 05/2008 - 01/2008
2	Wounds and Injuries (Trauma) 07/2006 - 09/2003

Drug/Important Bio-Agent (IBA)

42	Peptide Hydrolases (Proteases)FDA Link 05/2021 - 04/2002
16	Proteinase-Activated ReceptorsIBA 05/2021 - 10/2003
9	PAR-2 ReceptorIBA 12/2017 - 04/2002
9	Peptides (Polypeptides)IBA 04/2009 - 03/2003
7	CytokinesIBA 01/2022 - 06/2005
7	Capsaicin (Zostrix)FDA Link 01/2012 - 04/2003
6	Thrombin FDA Link 11/2021 - 03/2002
6	TrypsinIBA 09/2021 - 11/2002
5	ElafinIBA 01/2023 - 04/2011
5	Serine Proteases (Serine Protease)IBA 09/2021 - 06/2005
5	Analgesics (Analgesic Drugs)IBA 01/2021 - 03/2005
5	Opioid Analgesics (Opioids)IBA 01/2021 - 06/2006
5	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018 - 03/2003
5	Peroxidase (Myeloperoxidase)IBA 04/2013 - 04/2003
4	AcidsIBA 05/2021 - 09/2010
4	AntigensIBA 01/2021 - 02/2012
4	Messenger RNA (mRNA)IBA 01/2019 - 03/2003
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018 - 01/2013
4	Dextran SulfateIBA 01/2018 - 01/2014
4	Small Interfering RNA (siRNA)IBA 08/2015 - 06/2007
4	NeuropeptidesIBA 04/2013 - 09/2003
4	CarrageenanIBA 11/2009 - 03/2002
4	Calcitonin Gene-Related PeptideIBA 02/2007 - 09/2003
3	Insulin (Novolin)FDA Link 01/2022 - 03/2010
3	VaccinesIBA 01/2021 - 01/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 05/2013
3	PAR-1 ReceptorIBA 07/2018 - 03/2003
3	Tryptases (Tryptase)IBA 01/2017 - 11/2002
3	Phenobarbital (Luminal)FDA Link 02/2016 - 11/2002
3	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2015 - 04/2011
3	salicylhydroxamic acid (SHAM)IBA 01/2012 - 06/2006
3	Dextrans (Dextran)FDA Link 04/2011 - 11/2004
3	Calcium Channels (Calcium Channel)IBA 01/2011 - 08/2009
3	Formaldehyde (Formol)FDA Link 11/2009 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 10/2007 - 09/2004
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2006 - 04/2003
2	CationsIBA 03/2024 - 05/2004
2	Glutens (Glutelin)IBA 01/2023 - 01/2019
2	Pancreatic Elastase (Elastase)IBA 01/2021 - 01/2019
2	Ibuprofen (Motrin)FDA LinkGeneric 01/2020 - 05/2013
2	Protein Isoforms (Isoforms)IBA 01/2019 - 06/2007
2	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2019 - 07/2006
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019 - 08/2012
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 05/2013
2	LipidsIBA 11/2017 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 05/2013
2	InterleukinsIBA 05/2016 - 09/2005
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2016 - 07/2013
2	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 01/2016 - 08/2015
2	Arachidonic Acid (Vitamin F)IBA 01/2016 - 01/2011
2	Ion Channels (Ion Channel)IBA 07/2015 - 02/2007
2	Interleukin-10 (Interleukin 10)IBA 02/2015 - 09/2005
2	EicosanoidsIBA 08/2013 - 01/2013
2	lipoxin A4IBA 07/2013 - 01/2013
2	Protease Inhibitors (Protease Inhibitor)IBA 06/2013 - 04/2011
2	Morphine (MS Contin)FDA LinkGeneric 05/2013 - 01/2012
2	SolutionsIBA 01/2012 - 09/2010
2	Sulfonic AcidsIBA 04/2011 - 11/2004
2	CalciumIBA 01/2011 - 09/2008
2	LigandsIBA 01/2011 - 10/2004
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 09/2010 - 11/2004
2	Substance PIBA 02/2007 - 05/2004
2	TRPV Cation ChannelsIBA 09/2006 - 05/2004
2	Protons (Proton)IBA 09/2006 - 05/2004

Therapy/Procedure

4	Injections 08/2015 - 04/2002
3	Oral Administration 01/2018 - 10/2012
2	Immunotherapy 01/2024 - 12/2020
2	Spinal Injections 08/2015 - 04/2010
2	Intra-Articular Injections 06/2012 - 03/2009
2	Analgesia 02/2012 - 11/2009